Annual Net Income
-$373.63 M
-$78.28 M-26.50%
December 31, 2023
Summary
- As of February 18, 2025, MDGL annual net profit is -$373.63 million, with the most recent change of -$78.28 million (-26.50%) on December 31, 2023.
- During the last 3 years, MDGL annual net income has fallen by -$171.39 million (-84.74%).
- MDGL annual net income is now -572.42% below its all-time high of $79.09 million, reached on December 31, 2009.
Performance
MDGL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$106.96 M
+$45.01 M+29.62%
September 30, 2024
Summary
- As of February 18, 2025, MDGL quarterly net profit is -$106.96 million, with the most recent change of +$45.01 million (+29.62%) on September 30, 2024.
- Over the past year, MDGL quarterly net income has stayed the same.
- MDGL quarterly net income is now -190.56% below its all-time high of $118.12 million, reached on September 30, 2009.
Performance
MDGL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$518.67 M
-$8.22 M-1.61%
September 30, 2024
Summary
- As of February 18, 2025, MDGL TTM net profit is -$518.67 million, with the most recent change of -$8.22 million (-1.61%) on September 30, 2024.
- Over the past year, MDGL TTM net income has stayed the same.
- MDGL TTM net income is now -656.04% below its all-time high of $93.28 million, reached on March 31, 2010.
Performance
MDGL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MDGL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.5% | 0.0% | 0.0% |
| 3 y3 years | -84.7% | 0.0% | 0.0% |
| 5 y5 years | -1038.7% | 0.0% | 0.0% |
MDGL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -86.0% | +29.6% | -114.5% | at low |
| 5 y | 5-year | -345.1% | at low | -285.6% | +29.6% | -517.9% | at low |
| alltime | all time | -572.4% | at low | -190.6% | +29.6% | -656.0% | at low |
Madrigal Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$106.96 M(-29.6%) | -$518.67 M(+1.6%) |
| Jun 2024 | - | -$151.97 M(+3.0%) | -$510.45 M(+14.9%) |
| Mar 2024 | - | -$147.54 M(+31.5%) | -$444.27 M(+18.9%) |
| Dec 2023 | -$373.63 M(+26.5%) | -$112.19 M(+13.6%) | -$373.63 M(+7.6%) |
| Sep 2023 | - | -$98.74 M(+15.1%) | -$347.34 M(+5.3%) |
| Jun 2023 | - | -$85.80 M(+11.6%) | -$329.80 M(+4.8%) |
| Mar 2023 | - | -$76.90 M(-10.5%) | -$314.73 M(+6.6%) |
| Dec 2022 | -$295.35 M(+22.1%) | -$85.91 M(+5.8%) | -$295.35 M(+7.8%) |
| Sep 2022 | - | -$81.20 M(+14.8%) | -$273.99 M(+7.1%) |
| Jun 2022 | - | -$70.73 M(+23.0%) | -$255.90 M(+3.7%) |
| Mar 2022 | - | -$57.52 M(-10.9%) | -$246.82 M(+2.1%) |
| Dec 2021 | -$241.85 M(+19.6%) | -$64.55 M(+2.3%) | -$241.85 M(+2.3%) |
| Sep 2021 | - | -$63.10 M(+2.4%) | -$236.42 M(+2.2%) |
| Jun 2021 | - | -$61.65 M(+17.3%) | -$231.28 M(+5.8%) |
| Mar 2021 | - | -$52.55 M(-11.1%) | -$218.66 M(+8.1%) |
| Dec 2020 | -$202.24 M(+140.9%) | -$59.12 M(+2.0%) | -$202.24 M(+18.4%) |
| Sep 2020 | - | -$57.96 M(+18.2%) | -$170.86 M(+27.2%) |
| Jun 2020 | - | -$49.02 M(+35.7%) | -$134.33 M(+27.9%) |
| Mar 2020 | - | -$36.13 M(+30.3%) | -$105.00 M(+25.1%) |
| Dec 2019 | -$83.95 M(+155.9%) | -$27.74 M(+29.5%) | -$83.95 M(+24.0%) |
| Sep 2019 | - | -$21.43 M(+8.8%) | -$67.68 M(+23.6%) |
| Jun 2019 | - | -$19.70 M(+30.6%) | -$54.77 M(+31.9%) |
| Mar 2019 | - | -$15.08 M(+31.4%) | -$41.53 M(+26.6%) |
| Dec 2018 | -$32.81 M(+5.3%) | -$11.47 M(+34.8%) | -$32.81 M(+10.2%) |
| Sep 2018 | - | -$8.51 M(+31.8%) | -$29.78 M(+0.5%) |
| Jun 2018 | - | -$6.46 M(+1.5%) | -$29.63 M(-6.0%) |
| Mar 2018 | - | -$6.36 M(-24.6%) | -$31.52 M(+1.2%) |
| Dec 2017 | -$31.15 M(+18.1%) | -$8.45 M(+1.0%) | -$31.15 M(+2.3%) |
| Sep 2017 | - | -$8.36 M(+0.2%) | -$30.46 M(-15.7%) |
| Jun 2017 | - | -$8.35 M(+39.1%) | -$36.14 M(+17.8%) |
| Mar 2017 | - | -$6.00 M(-22.6%) | -$30.67 M(+16.2%) |
| Dec 2016 | -$26.39 M(+285.5%) | -$7.75 M(-44.8%) | -$26.39 M(+28.6%) |
| Sep 2016 | - | -$14.05 M(+388.3%) | -$20.52 M(+148.1%) |
| Jun 2016 | - | -$2.88 M(+68.0%) | -$8.27 M(-67.2%) |
| Mar 2016 | - | -$1.71 M(-9.0%) | -$25.20 M(-43.0%) |
| Dec 2015 | -$6.84 M(-92.1%) | -$1.88 M(+4.6%) | -$44.19 M(-29.5%) |
| Sep 2015 | - | -$1.80 M(-90.9%) | -$62.66 M(-22.5%) |
| Jun 2015 | - | -$19.80 M(-4.4%) | -$80.83 M(-3.0%) |
| Mar 2015 | - | -$20.71 M(+1.7%) | -$83.31 M(-3.3%) |
| Dec 2014 | -$86.16 M | -$20.35 M(+1.9%) | -$86.16 M(-4.2%) |
| Sep 2014 | - | -$19.97 M(-10.4%) | -$89.97 M(-2.8%) |
| Jun 2014 | - | -$22.29 M(-5.4%) | -$92.52 M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$23.56 M(-2.5%) | -$93.02 M(+3.1%) |
| Dec 2013 | -$90.19 M(+43.6%) | -$24.16 M(+7.3%) | -$90.19 M(+7.2%) |
| Sep 2013 | - | -$22.52 M(-1.2%) | -$84.15 M(+9.8%) |
| Jun 2013 | - | -$22.79 M(+9.9%) | -$76.63 M(+11.9%) |
| Mar 2013 | - | -$20.73 M(+14.4%) | -$68.47 M(+9.0%) |
| Dec 2012 | -$62.79 M(+32.5%) | -$18.12 M(+20.9%) | -$62.79 M(+13.3%) |
| Sep 2012 | - | -$15.00 M(+2.6%) | -$55.41 M(+4.3%) |
| Jun 2012 | - | -$14.62 M(-2.9%) | -$53.15 M(+4.2%) |
| Mar 2012 | - | -$15.05 M(+40.1%) | -$51.03 M(+7.7%) |
| Dec 2011 | -$47.38 M(+26.5%) | -$10.74 M(-15.6%) | -$47.38 M(+4.2%) |
| Sep 2011 | - | -$12.73 M(+1.9%) | -$45.46 M(+5.8%) |
| Jun 2011 | - | -$12.50 M(+9.7%) | -$42.99 M(+8.7%) |
| Mar 2011 | - | -$11.40 M(+29.2%) | -$39.56 M(+5.6%) |
| Dec 2010 | -$37.47 M(-147.4%) | -$8.82 M(-14.0%) | -$37.47 M(+5.0%) |
| Sep 2010 | - | -$10.26 M(+13.1%) | -$35.68 M(-138.5%) |
| Jun 2010 | - | -$9.07 M(-2.5%) | $92.70 M(-0.6%) |
| Mar 2010 | - | -$9.31 M(+32.3%) | $93.28 M(+17.9%) |
| Dec 2009 | $79.09 M(-185.4%) | -$7.04 M(-106.0%) | $79.09 M(+31.4%) |
| Sep 2009 | - | $118.12 M(-1490.5%) | $60.17 M(-171.4%) |
| Jun 2009 | - | -$8.49 M(-63.8%) | -$84.27 M(-14.4%) |
| Mar 2009 | - | -$23.50 M(-9.5%) | -$98.47 M(+6.3%) |
| Dec 2008 | -$92.62 M(+45.9%) | -$25.95 M(-1.4%) | -$92.62 M(+12.7%) |
| Sep 2008 | - | -$26.32 M(+16.0%) | -$82.19 M(+16.2%) |
| Jun 2008 | - | -$22.69 M(+28.6%) | -$70.74 M(+9.2%) |
| Mar 2008 | - | -$17.65 M(+13.7%) | -$64.79 M(+2.0%) |
| Dec 2007 | -$63.49 M(+10.9%) | -$15.52 M(+4.4%) | -$63.49 M(+5.0%) |
| Sep 2007 | - | -$14.88 M(-11.1%) | -$60.46 M(+1.6%) |
| Jun 2007 | - | -$16.74 M(+2.4%) | -$59.51 M(+3.1%) |
| Mar 2007 | - | -$16.36 M(+31.0%) | -$57.70 M(+2.5%) |
| Dec 2006 | -$57.27 M(-16.8%) | -$12.49 M(-10.3%) | -$56.27 M(-5.1%) |
| Sep 2006 | - | -$13.93 M(-6.7%) | -$59.27 M(-17.7%) |
| Jun 2006 | - | -$14.93 M(0.0%) | -$72.03 M(-14.0%) |
| Mar 2006 | - | -$14.93 M(-3.6%) | -$83.79 M(-3.4%) |
| Dec 2005 | -$68.86 M(+49.9%) | -$15.49 M(-41.9%) | -$86.72 M(+21.7%) |
| Sep 2005 | - | -$26.69 M(0.0%) | -$71.23 M(+59.9%) |
| Jun 2005 | - | -$26.69 M(+49.4%) | -$44.54 M(+149.4%) |
| Mar 2005 | - | -$17.86 M(+103.9%) | -$17.86 M(+103.9%) |
| Dec 2004 | -$45.93 M(+64.8%) | - | - |
| Mar 2004 | - | -$8.76 M | -$8.76 M |
| Dec 2003 | -$27.88 M(-22.9%) | - | - |
| Dec 2002 | -$36.15 M(+9389.2%) | - | - |
| Dec 2001 | -$381.00 K | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual net profit?
- What is the all time high annual net income for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual net income year-on-year change?
- What is Madrigal Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly net income year-on-year change?
- What is Madrigal Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM net income year-on-year change?
What is Madrigal Pharmaceuticals annual net profit?
The current annual net income of MDGL is -$373.63 M
What is the all time high annual net income for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual net profit is $79.09 M
What is Madrigal Pharmaceuticals annual net income year-on-year change?
Over the past year, MDGL annual net profit has changed by -$78.28 M (-26.50%)
What is Madrigal Pharmaceuticals quarterly net profit?
The current quarterly net income of MDGL is -$106.96 M
What is the all time high quarterly net income for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly net profit is $118.12 M
What is Madrigal Pharmaceuticals quarterly net income year-on-year change?
Over the past year, MDGL quarterly net profit has changed by $0.00 (0.00%)
What is Madrigal Pharmaceuticals TTM net profit?
The current TTM net income of MDGL is -$518.67 M
What is the all time high TTM net income for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM net profit is $93.28 M
What is Madrigal Pharmaceuticals TTM net income year-on-year change?
Over the past year, MDGL TTM net profit has changed by $0.00 (0.00%)